CUPERTINO, Calif., Nov. 3, 2010 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended September 30, 2010. Total revenues were $8.1 million for the three months ended September 30, 2010 compared to $8.4 million for the three months ended September 30, 2009; revenues in the 2009 period […]
DURECT Corporation Announces Third Quarter 2010 Financial Results Read More »
CUPERTINO, Calif., Nov. 2, 2010 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) announced today that it has been awarded grants totaling $733,438 to advance our programs in post-operative pain relief, attention deficit disorder (ADHD) and chronic diseases treated with biologic agents. The grants are being awarded under the Patient Protection and Affordable Care Act
CUPERTINO, Calif., Oct 27, 2010 /PRNewswire via COMTEX/ — In conjunction with DURECT Corporation’s (Nasdaq: DRRX) third quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Wednesday, November 3, 2010 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo:
DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call Read More »
CUPERTINO, Calif., Sep 7, 2010 (GlobeNewswire via COMTEX) — DURECT Corporation (Nasdaq:DRRX) announced today that management is scheduled to present at three upcoming healthcare conferences. — Joe Stauffer, Chief Medical Officer and EVP-Corporate Strategy, will deliver a talk entitled “FDA Regulations and Testing for Pain Products” at the National Conference on Pain for Frontline Practitioners
DURECT Corporation to Participate in Upcoming Healthcare Conferences Read More »
CUPERTINO, Calif., Aug 04, 2010 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended June 30, 2010. Total revenues were $7.3 million for the three months ended June 30, 2010 compared to $4.9 million for the three months ended June 30, 2009. Net loss for the three
DURECT Corporation Announces Second Quarter 2010 Financial Results Read More »
CUPERTINO, Calif., July 29, 2010 /PRNewswire via COMTEX/ — In conjunction with DURECT Corporation’s (Nasdaq: DRRX) second quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Wednesday, August 4, 2010 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo:
DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call Read More »
CUPERTINO, Calif., July 28, 2010 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) announced today that Matthew J. Hogan, Chief Financial Officer, will be presenting at the BMO Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5 at 1:45 p.m. Eastern Time. The conference is being held at the Sheraton New York
DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference Read More »
CUPERTINO, Calif., July 1, 2010 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) announced today that it has secured a committed equity financing facility under which it may sell up to $50 million of its registered common stock to Azimuth Opportunity Ltd. for a term of 24 months. DURECT is not obligated to utilize any
DURECT Corporation Secures $50 Million Committed Equity Financing Facility Read More »
CUPERTINO, Calif., June 16, 2010 /PRNewswire via COMTEX/ –DURECT Corporation (Nasdaq: DRRX) announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR(TM) (also known as SABER(TM)-bupivacaine or Optesia(TM) in the E.U.), a proprietary product under development for the treatment of post-surgical pain. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) This hysterectomy trial
CUPERTINO, Calif., June 7, 2010 /PRNewswire via COMTEX/ –In conjunction with the announcement of a POSIDUR(TM) (SABER(TM)-Bupivacaine) collaboration between DURECT Corporation (Nasdaq: DRRX) and Hospira, Inc. (NYSE: HSP), you are invited to listen to a conference call that will be broadcast live over the internet on Monday, June 7, 2010 at 5:00 pm Eastern Time
